Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviourALVAREZ-LOBOS, M; AROSTEGUI, J. I; SANS, M et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 4, pp 429-440, issn 0269-2813, 12 p.Article

Behcet's disease and hereditary periodic fever syndromes : Casual association or causal relationship ?ESPINOSA, G; AROSTEGUI, J. I; PLAZA, S et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 4, pp S.64-S.66, issn 0392-856X, SUP38Article

Possible association between NOD2 variants and joint surgery in psoriatic arthritisGRAELL, E; AROSTEGUI, J. I; SANMARTI, R et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 1, pp 30-34, issn 0392-856X, 5 p.Article